XML 53 R38.htm IDEA: XBRL DOCUMENT v3.22.4
Activity in Company's Allowance for Doubtful Accounts (Detail) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Accounts, Notes, Loans and Financing Receivable [Line Items]      
Balance at Beginning of Period $ 3.3 $ 3.3 $ 1.0
Provision 6.7 5.6 5.5
Recoveries 0.9 0.8 0.6
Accounts Written Off 7.6 6.5 4.4
Regulatory Defferals [1] (0.7) 0.1 0.6
Balance at End of Period 2.6 3.3 3.3
Electric      
Accounts, Notes, Loans and Financing Receivable [Line Items]      
Balance at Beginning of Period 2.0 1.6 0.6
Provision 4.2 3.3 2.9
Recoveries 0.3 0.4 0.3
Accounts Written Off 4.4 3.4 2.6
Regulatory Defferals [1] (0.5) 0.1 0.4
Balance at End of Period 1.6 2.0 1.6
Gas      
Accounts, Notes, Loans and Financing Receivable [Line Items]      
Balance at Beginning of Period 1.3 1.7 0.4
Provision 2.5 2.3 2.6
Recoveries 0.6 0.4 0.3
Accounts Written Off 3.2 3.1 1.8
Regulatory Defferals [1] (0.2)   0.2
Balance at End of Period $ 1.0 $ 1.3 $ 1.7
[1] In 2021 and 2020, the Company recorded higher than normal expected bad debt expense due to the coronavirus pandemic. The incremental bad debt expense amounts were previously deferred as regulatory assets based on certain regulatory proceedings and management’s view that such amounts were probable of recovery. Based on actual billing and collections experience, the Company has not deferred any incremental bad debt expense as a regulatory asset as of December 31, 2022.